|
|
cation transport
|
GO:0006812 |
399 |
0.315
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.269
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.197
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.185
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.182
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.181
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.180
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.160
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.159
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.154
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.144
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.144
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.139
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.133
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.126
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.117
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.117
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.116
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.115
|
|
|
|
regulation of calcium ion transport
|
GO:0051924 |
69 |
0.114
|
|
|
|
regulation of ion homeostasis
|
GO:2000021 |
64 |
0.113
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.111
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.111
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.102
|
|
|
|
calcium ion transmembrane transport
|
GO:0070588 |
85 |
0.098
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.097
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.093
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.090
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.089
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.084
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.083
|
|
|
|
cytosolic calcium ion homeostasis
|
GO:0051480 |
70 |
0.080
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.075
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.074
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.072
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.069
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.068
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.067
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.064
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.063
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.062
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.062
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.061
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.059
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.059
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.059
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.058
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.055
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.055
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.055
|
|
|
|
positive regulation of cytosolic calcium ion concentration
|
GO:0007204 |
65 |
0.053
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.053
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.053
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.052
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.052
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.051
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.050
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.050
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.049
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.049
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.049
|
|
|
|
cytosolic calcium ion transport
|
GO:0060401 |
48 |
0.048
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.046
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.044
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.044
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.043
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.042
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.041
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.040
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.040
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.039
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.039
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.039
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.038
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.038
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.038
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.037
|
|
|
|
release of sequestered calcium ion into cytosol
|
GO:0051209 |
42 |
0.037
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.037
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.037
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.037
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.037
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.036
|
|
|
|
calcium ion transport into cytosol
|
GO:0060402 |
48 |
0.036
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.035
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.035
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.034
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.034
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.033
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.033
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.033
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.033
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.033
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.033
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.033
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.033
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.032
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.032
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.031
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.031
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.031
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.031
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.031
|
|
|
|
negative regulation of homeostatic process
|
GO:0032845 |
71 |
0.031
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.031
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.031
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.031
|
|
|
|
regulation of reactive oxygen species biosynthetic process
|
GO:1903426 |
2 |
0.031
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.030
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.030
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.030
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.030
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.030
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.030
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.030
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.029
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.029
|
|
|
|
regulation of myotube differentiation
|
GO:0010830 |
62 |
0.029
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.029
|
|
|
|
dephosphorylation
|
GO:0016311 |
129 |
0.029
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.028
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.028
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.028
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.028
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.027
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.027
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.027
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.027
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.026
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.026
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.026
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.026
|
|
|
|
alpha beta t cell activation
|
GO:0046631 |
91 |
0.026
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.026
|
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.025
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.025
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.025
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.025
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.025
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.025
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.024
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.024
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.024
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.024
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.024
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.024
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.024
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.024
|
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.024
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.024
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.023
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.023
|
|
|
|
regulation of cellular carbohydrate metabolic process
|
GO:0010675 |
75 |
0.023
|
|
|
|
detection of chemical stimulus involved in sensory perception of taste
|
GO:0050912 |
3 |
0.023
|
|
|
|
regulation of peptide transport
|
GO:0090087 |
91 |
0.023
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.023
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.023
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.023
|
|
|
|
regulation of circadian sleep wake cycle
|
GO:0042749 |
3 |
0.023
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.023
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.022
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.022
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.022
|
|
|
|
cyclic nucleotide metabolic process
|
GO:0009187 |
59 |
0.022
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.022
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.022
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.021
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.021
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.021
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.021
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.021
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.021
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.021
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.021
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.021
|
|
|
|
mesodermal cell migration
|
GO:0008078 |
4 |
0.021
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.021
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.021
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.021
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.021
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.021
|
|
|
|
negative regulation of angiogenesis
|
GO:0016525 |
25 |
0.021
|
|
|
|
regulation of reproductive process
|
GO:2000241 |
66 |
0.020
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.020
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.020
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.020
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.020
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.020
|
|
|
|
regulation of systemic arterial blood pressure mediated by a chemical signal
|
GO:0003044 |
33 |
0.020
|
|
|
|
negative regulation of blood vessel morphogenesis
|
GO:2000181 |
25 |
0.020
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.020
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.020
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.020
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.020
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.019
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.019
|
|
|
|
cellular modified amino acid metabolic process
|
GO:0006575 |
63 |
0.019
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.019
|
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
78 |
0.019
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.019
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.019
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.019
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.019
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.018
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.018
|
|
|
|
phospholipase c activating g protein coupled receptor signaling pathway
|
GO:0007200 |
26 |
0.018
|
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.018
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.018
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.018
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.018
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.018
|
|
|
|
somite development
|
GO:0061053 |
81 |
0.018
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.018
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.018
|
|
|
|
adult locomotory behavior
|
GO:0008344 |
91 |
0.018
|
|
|
|
regulation of calcium ion transport into cytosol
|
GO:0010522 |
31 |
0.018
|
|
|
|
regulation of calcium ion transmembrane transporter activity
|
GO:1901019 |
20 |
0.018
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.018
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.018
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.018
|
|
|
|
ventral spinal cord development
|
GO:0021517 |
48 |
0.018
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.018
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.017
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.017
|
|
|
|
alpha beta t cell differentiation involved in immune response
|
GO:0002293 |
30 |
0.017
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.017
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.017
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.017
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.017
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.017
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.017
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.017
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.017
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.017
|
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.017
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.017
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.017
|
|
|
|
proteoglycan metabolic process
|
GO:0006029 |
38 |
0.017
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.017
|
|
|
|
positive regulation of blood circulation
|
GO:1903524 |
22 |
0.017
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.016
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.016
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.016
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.016
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.016
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.016
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.016
|
|
|
|
neuromuscular process
|
GO:0050905 |
99 |
0.016
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.016
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.016
|
|
|
|
cytokine secretion
|
GO:0050663 |
72 |
0.016
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.016
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.016
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.016
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.016
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.016
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.016
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.015
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.015
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.015
|
|
|
|
positive regulation of vasoconstriction
|
GO:0045907 |
4 |
0.015
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.015
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.015
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.015
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.015
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
79 |
0.015
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.015
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.015
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.015
|
|
|
|
positive regulation of growth hormone secretion
|
GO:0060124 |
3 |
0.015
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.015
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.015
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.015
|
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.014
|
|
|
|
ribose phosphate biosynthetic process
|
GO:0046390 |
59 |
0.014
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.014
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.014
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.014
|
|
|
|
regulation of cation channel activity
|
GO:2001257 |
22 |
0.014
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.014
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.014
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.014
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.014
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.014
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.014
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.014
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.014
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.014
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.014
|
|
|
|
hair follicle development
|
GO:0001942 |
85 |
0.014
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.014
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.014
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.014
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.014
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.014
|
|
|
|
cellular response to steroid hormone stimulus
|
GO:0071383 |
33 |
0.014
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.014
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.014
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.013
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.013
|
|
|
|
regulation of circadian rhythm
|
GO:0042752 |
58 |
0.013
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.013
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.013
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.013
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.013
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.013
|
|
|
|
adult walking behavior
|
GO:0007628 |
41 |
0.013
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
68 |
0.013
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.013
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.013
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.013
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.013
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.013
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.013
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.013
|
|
|
|
positive regulation of ion transport
|
GO:0043270 |
65 |
0.013
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.013
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.013
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.013
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.013
|
|
|
|
notch signaling pathway
|
GO:0007219 |
71 |
0.013
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.013
|
|
|
|
memory
|
GO:0007613 |
58 |
0.013
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.013
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.013
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.013
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.013
|
|
|
|
negative regulation of neuron differentiation
|
GO:0045665 |
101 |
0.013
|
|
|
|
negative regulation of secretion
|
GO:0051048 |
61 |
0.013
|
|
|
|
ribonucleotide biosynthetic process
|
GO:0009260 |
59 |
0.013
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.013
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.013
|
|
|
|
catecholamine uptake
|
GO:0090493 |
4 |
0.013
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.013
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.013
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.013
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.013
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.013
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.013
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.013
|
|
|
|
lymphocyte activation involved in immune response
|
GO:0002285 |
93 |
0.013
|
|
|
|
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002822 |
87 |
0.013
|
|
|
|
mesoderm morphogenesis
|
GO:0048332 |
64 |
0.012
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.012
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.012
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.012
|
|
|
|
regulation of circadian sleep wake cycle sleep
|
GO:0045187 |
3 |
0.012
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.012
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.012
|
|
|
|
purine ribonucleotide biosynthetic process
|
GO:0009152 |
59 |
0.012
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.012
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.012
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.012
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.012
|
|
|
|
leukocyte homeostasis
|
GO:0001776 |
79 |
0.012
|
|
|
|
rna interference
|
GO:0016246 |
2 |
0.012
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.012
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.012
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.012
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.012
|
|
|
|
coagulation
|
GO:0050817 |
78 |
0.012
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.012
|
|
|
|
regulation of t cell proliferation
|
GO:0042129 |
92 |
0.012
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.012
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.012
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.012
|
|
|
|
hemostasis
|
GO:0007599 |
78 |
0.012
|
|
|
|
smooth muscle contraction
|
GO:0006939 |
44 |
0.012
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.012
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.012
|
|
|
|
regulation of peptide secretion
|
GO:0002791 |
77 |
0.012
|
|
|
|
skeletal muscle fiber development
|
GO:0048741 |
58 |
0.012
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.012
|
|
|
|
cell differentiation in spinal cord
|
GO:0021515 |
53 |
0.012
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.012
|
|
|
|
negative regulation of keratinocyte differentiation
|
GO:0045617 |
4 |
0.012
|
|
|
|
embryonic heart tube development
|
GO:0035050 |
65 |
0.012
|
|
|
|
regulation of fibroblast proliferation
|
GO:0048145 |
34 |
0.012
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.012
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.012
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.011
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.011
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.011
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.011
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.011
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.011
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.011
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.011
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.011
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
70 |
0.011
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.011
|
|
|
|
central nervous system neuron development
|
GO:0021954 |
67 |
0.011
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.011
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.011
|
|
|
|
b cell activation involved in immune response
|
GO:0002312 |
50 |
0.011
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.011
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.011
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.011
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.011
|
|
|
|
regulation of adaptive immune response
|
GO:0002819 |
90 |
0.011
|
|
|
|
regulation of stem cell proliferation
|
GO:0072091 |
78 |
0.011
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.011
|
|
|
|
eosinophil migration
|
GO:0072677 |
3 |
0.011
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.011
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.011
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.011
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.011
|
|
|
|
cd4 positive alpha beta t cell differentiation
|
GO:0043367 |
41 |
0.011
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.011
|
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.011
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.011
|
|
|
|
positive regulation of reactive oxygen species metabolic process
|
GO:2000379 |
11 |
0.011
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.011
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.011
|
|
|
|
potassium ion transport
|
GO:0006813 |
52 |
0.011
|
|
|
|
positive regulation of t cell activation
|
GO:0050870 |
101 |
0.011
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.011
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.011
|
|
|
|
carbon catabolite activation of transcription
|
GO:0045991 |
4 |
0.011
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.011
|
|
|
|
segmentation
|
GO:0035282 |
93 |
0.011
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.011
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.011
|
|
|
|
g protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger
|
GO:0007187 |
55 |
0.011
|
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.011
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.010
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.010
|
|
|
|
fertilization
|
GO:0009566 |
127 |
0.010
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.010
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.010
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.010
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.010
|
|
|
|
norepinephrine transport
|
GO:0015874 |
2 |
0.010
|
|
|
|
calcium mediated signaling
|
GO:0019722 |
46 |
0.010
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.010
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.010
|
|
|
|
cell fate specification
|
GO:0001708 |
72 |
0.010
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.010
|
|
|
|
gene silencing
|
GO:0016458 |
38 |
0.010
|
|
|
|
negative regulation of inflammatory response
|
GO:0050728 |
61 |
0.010
|
|
|
|
small molecule catabolic process
|
GO:0044282 |
71 |
0.010
|
|
|
|
regulation of auditory receptor cell differentiation
|
GO:0045607 |
4 |
0.010
|
|
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.010
|
|
|
|
dna recombination
|
GO:0006310 |
92 |
0.010
|
|
